ARYLALKYLAMINES, COMPOSITIONS, METHODS OF TREATMENT AND DIAGNOSIS, METHOD OF IDENTIFICATION OF COMPOUND Russian patent published in 2000 - IPC

Abstract RU 2147574 C1

FIELD: organic chemistry, medicine, pharmacy. SUBSTANCE: invention relates to a compound, methods and composition used for treatment of patients suffering with diseases that are characterized by anomal level of one or more components regulating or depending on one or more Ca2+-receptors. New compounds for these methods and compositions are developed also. Method involves administration to patient molecules at effective amount acting on one or more Ca2+-receptors and showing affinity to these receptors or exhibiting antagonistic properties. Preferably, molecule is able to act as a substance showing affinity or as antagonist to Ca2+-receptors of one or more but not all cell types taken among the group consisting of parathyroid cells, osseous osteoclasts, juxtaglomerular renal cells, cells of proximal transverse tubule, keratinocytes, thyroid parafollicular cells and placenta trophoblasts. Compositions have also a pharmaceutically acceptable carrier. EFFECT: specificity of effect of compounds, compositions and methods based on thereof. 65 cl, 6 tbl, 98 dwg, 23 ex

Similar patents RU2147574C1

Title Year Author Number
PHARMACEUTICAL COMPOSITION SHOWING ACTIVITY WITH RESPECT TO CALCIUM RECEPTOR, METHOD OF PATIENT TREATMENT, METHOD OF ANALYSIS OF COMPOUND EXHIBITING EFFECT ON ACTIVITY OF INORGANIC ION RECEPTOR, RECEPTOR-ENCODING NUCLEIC ACID, CALCIUM RECEPTOR 1993
  • Ehdvard F.Nemet
  • Ehdvard M.Braun
  • Stiven K.Khebert
  • Brehdford K. Van Vejgenen
  • Manuel' F.Balandrin
  • Forrest Kh.Fuller
  • Ehrik G.Del Mar
RU2146132C1
COMPOUNDS SHOWING ACTIVITY WITH RESPECT TO CALCIUM RECEPTORS (VERSIONS), PHARMACEUTICAL COMPOSITION AND METHODS OF TREATMENT (VERSIONS) 1995
  • Van Vagenen Brehdford K.
  • Moe Skott T.
  • Balandrin Manuehl' F.
  • Delmar Ehrik G.
  • Nemet Ehdvard F.
RU2195446C2
POLYPEPTIDE DERIVATIVES, METHOD OF CALCIUM CHANNEL INHIBITION 1993
  • Din M.Nejson Ii
  • Duglas Fillips
  • Nikolas Sakkomano
  • Robert A.Volkmann
RU2120945C1
POLYPEPTIDE OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS 1993
  • Duglas Fillips[Us]
  • Mehri E.Kelli[Us]
  • Nikolas A.Sakkomano[Us]
  • Robert A.Vol'Kmann[Us]
RU2104286C1
COMPOUNDS BEING ACTIVE AT A NEW SITE UPON RECEPTOR-OPERATED CALCIUM CANALS APPLIED FOR TREATING NEUROLOGICAL DISORDERS 1996
  • Alan L. Mjuller
  • Skott T. Moeh
  • Manuehl F. Balandrin
  • Ehrik Dzh. Delmar
  • Bredford K. Vanvagenen
  • Linda D. Artman
  • Robert M. Barmor
  • Dehril L. Smit
RU2246300C2
MODULATION OF EXPRESSION OF CYTOKINES TH1/TH2 BY RIBAVIRIN AND RIBAVIRIN ANALOGS IN ACTIVATED T-LYMPHOCYTES 1997
  • Tehm Robert
  • Rejmasejmi Kehndsejmi
  • Ehverett Devron
RU2186569C2
POLYPEPTIDE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT (VARIANTS); METHOD TO SUPPRESS THE ACTION OF AMINO ACID NEUROMEDIATORS 1993
  • Din M.Nehjson Ii[Us]
  • Robert T.Rono[Us]
  • Nikolas Sakkomano[Us]
  • Robert A.Volkman[Us]
  • Stiven D.Khek[Us]
RU2106358C1
COMPOUNDS ACTIVE IN NOVEL SITE ON RECEPTOR-REGULATING CALCIUM CHANNELS AND USED FOR TREATMENT OF NEUROLOGICAL DISTURBANCES AND DISEASES 1994
  • Mjuller Alan L.
  • Van Vagenen Brehdford S.
  • Delmar Ehrik G.
  • Balandrin Manuel' F.
  • Mo Skott T.
  • Artman Linda D.
  • Barmor Robert M.
RU2201224C2
MODULATION OF IMMUNE RESPONSE DUE TO RIBAVIRIN 1999
  • Tehm Robert
RU2211698C2
ANTI-SENSE OLIGONUCLEOTIDES FOR TREATING ALLERGY AND PROLIFERATION OF NEOPLASTIC CELLS 2005
  • Zemzoumi Khalid
  • Rentsi Paolo
RU2416412C2

RU 2 147 574 C1

Authors

Ehdvard F.Nemet

Brehdford K.Van Vejgenen

Manuel' F.Balandrin

Dates

2000-04-20Published

1992-08-21Filed